Gastroparesis with bezoar formation in patients treated with glucagon-like peptide-1 receptor agonists: potential relevance for bariatric and other gastric surgery.
作者信息
Preda Veronica, Khoo Skylar Su-Yee, Preda Tamara, Lord Reginald V
机构信息
Department of Endocrinology, Human and Health Sciences Macquarie University, Sydney, Australia.
Department of Surgery, University of Notre Dame School of Medicine, Sydney, Australia.
出版信息
BJS Open. 2023 Jan 6;7(1). doi: 10.1093/bjsopen/zrac169.
Abstract
摘要
相似文献
1
Gastroparesis with bezoar formation in patients treated with glucagon-like peptide-1 receptor agonists: potential relevance for bariatric and other gastric surgery.
BJS Open. 2023 Jan 6;7(1). doi: 10.1093/bjsopen/zrac169.
2
Looking beyond glucagon-like peptide-1 agonists: could antagonists offer a potential therapy for gastroparesis?
J Gastrointest Surg. 2024 Jul;28(7):1179-1180. doi: 10.1016/j.gassur.2024.04.028. Epub 2024 Apr 30.
3
Gastrointestinal phytobezoar following bariatric surgery: Systematic review.
Surg Obes Relat Dis. 2016 Nov;12(9):1747-1754. doi: 10.1016/j.soard.2016.09.003. Epub 2016 Sep 9.
4
Gastric bezoars: reassessment of clinical and radiographic findings in 19 patients.
Br J Radiol. 2009 Nov;82(983):901-7. doi: 10.1259/bjr/15256968. Epub 2009 May 11.
5
Phytobezoar leading to gastric outlet obstruction in a patient with diabetes.
BMJ Case Rep. 2014 Jun 13;2014:bcr2013200661. doi: 10.1136/bcr-2013-200661.
6
Frequency of GLP-1 receptor agonists use in diabetic patients diagnosed with delayed gastric emptying and their demographic profile.
J Investig Med. 2023 Jan;71(1):11-16. doi: 10.1136/jim-2022-002480.
7
[Gastric food bezoar as a complication of bariatric surgery. Case report and review of the literature].
Gastroenterol Hepatol. 2006 Feb;29(2):77-80. doi: 10.1157/13083903.
8
Update on gastroparesis.
Gastroenterol Nurs. 2006 May-Jun;29(3):239-44; quiz 245-6. doi: 10.1097/00001610-200605000-00007.
9
Gastric bezoar complicating laparoscopic adjustable gastric banding, and review of literature.
Obes Surg. 2003 Dec;13(6):948-50. doi: 10.1381/096089203322618849.
10
Exenatide and rare adverse events.
N Engl J Med. 2008 May 1;358(18):1969-70; discussion 1971-2. doi: 10.1056/NEJMc0707137.
引用本文的文献
1
Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis.
Anaesthesia. 2025 Jul;80(7):846-858. doi: 10.1111/anae.16601. Epub 2025 Apr 15.
2
Effectiveness of Adjuvant Semaglutide Following Bariatric Metabolic Surgery.
Obes Surg. 2025 Mar;35(3):694-700. doi: 10.1007/s11695-025-07703-0. Epub 2025 Feb 21.
本文引用的文献
1
9. Pharmacologic Approaches to Glycemic Treatment: .
Diabetes Care. 2021 Jan;44(Suppl 1):S111-S124. doi: 10.2337/dc21-S009.
2
Magnitude of slowing gastric emptying by glucagon-like peptide-1 receptor agonists determines the amelioration of postprandial glucose excursion in Japanese patients with type 2 diabetes.
J Diabetes Investig. 2020 Mar;11(2):389-399. doi: 10.1111/jdi.13115. Epub 2019 Jul 25.
3
Changes in insulin sensitivity and secretion after sleeve gastrectomy.
Br J Surg. 2016 Feb;103(3):242-8. doi: 10.1002/bjs.10039. Epub 2015 Nov 9.
4
Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia.
Regul Pept. 2013 Aug 10;185:1-8. doi: 10.1016/j.regpep.2013.04.001. Epub 2013 May 9.
5
Exenatide and rare adverse events.
N Engl J Med. 2008 May 1;358(18):1969-70; discussion 1971-2. doi: 10.1056/NEJMc0707137.
Zotero 插件